Results 11 to 20 of about 2,912,203 (303)

Clinical, pathological characteristics, and therapeutic outcomes of primary ovarian carcinoid tumors: a case series of 15 cases [PDF]

World Journal of Surgical Oncology
Background The exact characteristics of primary ovarian carcinoid tumors remain largely unknown because of the rarity of the cases. This study aimed to investigate the clinical features, pathological characteristics, and therapeutic outcomes of patients ...
Xinyue Dai, Suidan Chen, Simeng Yang
doaj   +2 more sources

Carcinoid tumors of the thymus [PDF]

Cancer, 1976
Three patients with carcinoid tumors of the anterior mediastinum are described. Study of these patients and an analysis of previously reported cases indicates that the thymus is the primary site of these tumors, which are probably related to the presence of Kulchitsky cells in normal thymus.
William R. Salyer, Diane C. Salyer, Joseph C. Eggleston   +2 more
openalex   +4 more sources

Heterogeneous tumor‐immune microenvironments between primary and metastatic carcinoid tumors differentially respond to anti‐PD‐L1 antibody therapy [PDF]

Thoracic Cancer, 2021
A pulmonary carcinoid tumor is a rare tumor that lacks a validated therapeutic approach for unresectable disease. Understanding the intersite tumor‐immune heterogeneity is essential to harness the immune system for cancer therapy.
Shinya Sakata, Kosuke Imamura, Yuka Tajima, Yuiko Masuda, Ryo Sato, Chieko Yoshida, Shinichiro Okamoto, Sho Saeki, Yusuke Tomita, Takuro Sakagami   +9 more
doaj   +2 more sources

The Efficacy of Endoscopic Submucosal Dissection of Type I Gastric Carcinoid Tumors Compared with Conventional Endoscopic Mucosal Resection

Gastroenterology Research and Practice, 2014
Background and Aims. Conventional endoscopic submucosal resection (EMR) of carcinoid tumors often involves the resection margin, which necessitates further intervention.
Hyung Hun Kim, Gwang Ha Kim, Ji Hyun Kim, Myung-Gyu Choi, Geun Am Song, Sung Eun Kim   +5 more
doaj   +2 more sources

Phase III study of pasireotide long-acting release in patients with metastatic neuroendocrine tumors and carcinoid symptoms refractory to available somatostatin analogues [PDF]

Drug Design, Development and Therapy, 2015
In a randomized, double-blind, Phase III study, we compared pasireotide long-acting release (pasireotide LAR) with octreotide long-acting repeatable (octreotide LAR) in managing carcinoid symptoms refractory to first-generation somatostatin analogues ...
E. Wolin, B. Jarzab, B. Eriksson, T. Walter, C. Toumpanakis, M. Morse, P. Tomassetti, M. Weber, D. Fogelman, J. Ramage, D. Poon, B. Gadbaw, Jiang Li, J. Pasieka, A. Mahamat, Fredrik Swahn, J. Newell-Price, W. Mansoor, K. Öberg   +18 more
semanticscholar   +5 more sources

Management of Carcinoid Tumors

The Annals of Thoracic Surgery, 2010
Primary bronchopulmonary carcinoids comprise a significant proportion of carcinoid tumors. The clinical presentation allows prediction of the diagnosis and cell type and directs evaluation and treatment. Young age, central tumor, and no nodal enlargement are highly suggestive of typical carcinoid. These patients require no further diagnostic or staging
F. Detterbeck
openaire   +4 more sources

Carcinoid Tumors [PDF]

The Oncologist, 2008
Abstract Carcinoid tumors are rare, slow-growing neuroendocrine tumors arising from the enterochromaffin cells disseminated throughout the gastrointestinal and bronchopulmonary systems. Though they have been traditionally classified based on embryologic site of origin, morphologic pattern, and silver affinity, newer classification ...
Scott N, Pinchot, Kyle, Holen, Rebecca S, Sippel, Herbert, Chen   +3 more
openaire   +3 more sources

Incidentally Found Rectal Carcinoid Tumor in a 46-Year-Old Female: The Potential for Complications and the Importance of Screening Guidelines

International Journal of Medical Students, 2023
BACKGROUND: Carcinoid tumors are rare neuroendocrine tumors that can be found in the gastrointestinal tract as well as other areas throughout the body.
Rebecca Lapides, Akash Shah, Shubhneet Bal, Vidhun Ramapriya   +3 more
doaj   +1 more source

International trends in pulmonary neuroendocrine cancer studies:a scientometric study

Einstein (São Paulo), 2022
Introduction Pulmonary neuroendocrine tumors account for approximately 20% of all primary lung tumors. Few studies summarize the current body of pulmonary neuroendocrine tumors studies worldwide.
Hugo Tanaka, Auro del Giglio
doaj   +1 more source

Duodenal carcinoid tumour – a case report [PDF]

, 2020
Duodenal carcinoids are rare tumours of the small intestine with heterogenous clinical and pathological characteristics. The long-term prognosis is very good if discovered in the early stages.
Alexescu, Teodora Gabriela, Buchman, Cristina, Domsa, Iacob, Milaciu, Mircea, Negrean, Vasile, Orasan, Olga Hilda, Para, Ioana, Perne, Mirela Georgiana   +7 more
core   +2 more sources